Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
tFUS Regulates the Nespas/miR-383-3p/SHP2 Axis
2026-08-19
This study identifies a molecular mechanism by which low-intensity transcranial focused ultrasound (tFUS) reduces post-stroke neuroinflammation. Its central finding is that tFUS protects against NLRP3 inflammasome activation through the microglial Nespas/miR-383-3p/SHP2 axis, providing a mechanistic basis for noninvasive neuromodulation after ischemic stroke.
-
HotStart™ 2X Green qPCR Master Mix Guide
2026-08-19
HotStart™ 2X Green qPCR Master Mix supports SYBR Green real-time PCR workflows where nonspecific products, primer-dimers, or variable reaction setup can compromise quantification. It is suited to DNA and cDNA assays, including gene expression analysis and RNA-seq validation, but it should not be treated as sequence-specific detection or as a substitute for melt-curve and control-based assay validation.
-
Neurotensin: Analytical Design for NTR1 Studies
2026-08-18
Neurotensin is a versatile Neurotensin receptor 1 activator for connecting GPCR trafficking with miR-133α modulation. This guide adds an analytical-quality framework, showing how spectral interference controls can improve interpretation of gastrointestinal cell assays.
-
KG-501: From CREB–KIX Mechanism to Translation
2026-08-18
KG-501 is a mechanism-focused probe for testing CREB–CBP KIX disruption in transcriptional, cancer, and macrophage models. This article places the compound within a translational framework, using colorectal cancer immunology findings to define appropriate evidence standards, assay strategies, and limitations.
-
B7H3×CD3 BiTE mRNA-LNPs in Cancer Therapy
2026-08-17
Huang and colleagues developed an ionizable lipid nanoparticle system for delivering mRNA encoding a B7H3×CD3 bispecific T-cell engager. Their findings show that a single intravenous administration produced sustained BiTE expression and durable antitumor activity in models of hematologic malignancy and melanoma, addressing major limitations of recombinant BiTE therapy.
-
PBS Liposomes for Macrophage Control Studies
2026-08-17
PBS Liposomes provide a phagocytosis-matched negative control that separates liposome handling effects from clodronate-mediated macrophage depletion. This workflow shows how to pair them with depletion, uptake, cytokine, and TRPM3-related assays for more defensible causal conclusions.
-
Beyond Viability: Measuring Drug Responses in Cancer
2026-08-16
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of anticancer drug response. This framework supports more interpretable in vitro screening by aligning endpoint selection and sampling time with the biological process being measured.
-
Caffeine N2379: Reproducible Cell Assays
2026-08-15
This scenario-based guide explains how Caffeine (SKU N2379) can support better-controlled viability, proliferation, and cytotoxicity experiments. It covers assay interpretation, solvent compatibility, concentration planning, combination studies, and evidence-based vendor selection.
-
CBD, FAAH, and Orofacial Inflammatory Pain
2026-08-14
A 2026 Brain Research Bulletin study shows that cannabidiol reduces both nociceptive and pain-related affective abnormalities in mouse inflammatory pain models through coordinated peripheral and central endocannabinoid mechanisms. Its design links FAAH, anandamide, inflammatory mediators, trigeminal activity, and amygdala serotonin dynamics, providing a framework for interpreting multidimensional analgesic responses.
-
CBD Attenuates Orofacial Pain and Affective Deficits
2026-08-14
This 2026 study shows that cannabidiol (CBD) acts across peripheral inflammatory pathways, central pain circuits, and affective networks in mouse models. Its combination of behavioral, biochemical, receptor-related, and fiber-photometry analyses provides a mechanistic framework for treating both orofacial pain and associated emotional and cognitive disturbances.
-
Extracellular Vesicle Release Inhibitors in TNBC
2026-08-13
McNamee et al. systematically compared four pharmacological strategies and their combinations for suppressing extracellular vesicle release from triple-negative breast cancer models. The study shows that heterogeneous EV populations collectively contribute to aggressive trait transfer and that substantial, but incomplete, release inhibition produces only a partial reduction in recipient-cell effects.
-
Medroxyprogesterone Acetate: Applied Lab Workflows
2026-08-13
Medroxyprogesterone acetate enables controlled studies of progestin signaling across renal, reproductive, and neurobiology models. This workflow-focused guide covers dose design, solvent handling, receptor-aware controls, and troubleshooting for more reproducible MPA experiments.
-
Oseltamivir acid Research Workflows
2026-08-12
Oseltamivir acid is an active influenza neuraminidase inhibitor for pairing enzyme assays, cell-based influenza virus replication inhibition, resistance studies, and exploratory oncology experiments. This practical guide connects formulation, assay design, combination testing, and translational model selection while separating product-backed findings from workflow starting points.
-
Radioiodinated Balsalazide for Ulcerative Colitis Imaging
2026-08-12
The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for ulcerative colitis in mice. Its optimized labeling chemistry, 24-hour stability profile, and strong uptake in inflamed colon provide a practical framework for preclinical disease imaging while also highlighting important translational limitations.
-
Milk-Derived EV Uptake in Intestinal Stem Cell Models
2026-08-11
The reference study establishes a polarity-aware porcine intestinal stem cell platform to examine milk-derived extracellular vesicle uptake in models that better reproduce epithelial organization than conventional cell lines. Its findings link apical accessibility, intestinal region, stemness-related responses, and pharmacological sensitivity to endocytosis, providing a useful framework for studying extracellular vesicle biology in intestinal tissues.